المؤلفون: Shohreh Azimi, Dalebout T, Simon P. Jochems, Marion H. König, Pieter S. Hiemstra, Pothast Cr, Does Am, Jacqueline J. Janse, Verheij M, Zhang Jl, Meta Roestenberg, Anna H. Roukens, Maria Yazdanbakhsh, Corine Prins, Hermelijn H. Smits, Heemskerk Mh, Vries Jj, Hagedoorn Rs, Sesmu M. Arbous, Yvonne C. M. Kruize, Tamar Tak, Kikkert M, Myeni Sk

مصطلحات موضوعية: medicine.anatomical_structure, Immune system, business.industry, Immunology, Cytotoxic T cell, Medicine, CD11c, Mucous membrane of nose, CD38, business, Interleukin-7 receptor, CD8, Respiratory tract

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::71eb7eba590ead45e8eed175124c86c3
https://doi.org/10.1101/2021.04.19.21255727

المؤلفون: Hans-Jochem Kolb, Fabio Ciceri, Claudio Bordignon, Phil Greenberg, J H F Falkenburg, Mohammed A. Sadat, Marco Bregni, Eva M. Weissinger, M. Lamana, Manuel Grez, Timothy W. Austin, Alexis Grande, Mirjam H.M. Heemskerk, Zulma Magnani, Sabrina Cazzaniga, Alessandro Aiuti, Anton Hagenbeek, Saskia B. Ebeling, Steven M. Kornblau, Claudia Benati, Fulvio Mavilio, Sara Deola, Francesco Lotti, Catia Traversari, Mary C. Dinauer, Anton C.M. Martens, Giuliana Ferrari, Shimon Slavin, M. Weber, J. F. Apperley, Frank C. Marini, Chiara Bonini, Sarah Marktel, Corrado Gallo-Stampino, Salvatore Toma, Marina Radrizzani, Juan A. Bueren, Martino Introna

المساهمون: University of Groningen, Bonini, MARIA CHIARA, Grez, M, Traversari, C, Ciceri, Fabio, Marktel, S, Ferrari, Giuliana, Dinauer, M, Sadat, M, Aiuti, Alessandro, Deola, S, Radrizzani, M, Hagenbeek, A, Apperley, J, Ebeling, S, Martens, A, Kolb, Hj, Weber, M, Lotti, F, Grande, A, Weissinger, E, Bueren, Ja, Lamana, M, Falkenburg, Jh, Heemskerk, Mh, Austin, T, Kornblau, S, Marini, F, Benati, C, Magnani, Z, Cazzaniga, S, Toma, S, GALLO STAMPINO, C, Introna, M, Slavin, S, Greenberg, Pd, Bregni, M, Mavilio, F, Bordignon, Claudio, Clinical Haematology

المصدر: Nature Medicine, 9(4), 367-369. Nature Publishing Group
Nature medicine, 9(4), 367-369. Nature Publishing Group

مصطلحات موضوعية: NGF Receptor, gene therapy, viral vectors, NGF receptor, Bone marrow transplantation, Genetic enhancement, General Medicine, Biology, Molecular biology, General Biochemistry, Genetics and Molecular Biology, Cell biology, Viral vector, Transduction (genetics), Multicenter study, Receptor, Gene

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5097d1b050ae159381d816fc339025d1
https://doi.org/10.1038/nm0403-367

المؤلفون: Schmidt NM; Division of Infection & Immunity, Institute of Immunity & Transplantation, University College London, London, UK., Wing PAC; Nuffield Department of Medicine, Oxford University, Oxford, UK., Diniz MO; Division of Infection & Immunity, Institute of Immunity & Transplantation, University College London, London, UK., Pallett LJ; Division of Infection & Immunity, Institute of Immunity & Transplantation, University College London, London, UK., Swadling L; Division of Infection & Immunity, Institute of Immunity & Transplantation, University College London, London, UK., Harris JM; Nuffield Department of Medicine, Oxford University, Oxford, UK., Burton AR; Division of Infection & Immunity, Institute of Immunity & Transplantation, University College London, London, UK., Jeffery-Smith A; Division of Infection & Immunity, Institute of Immunity & Transplantation, University College London, London, UK., Zakeri N; Division of Infection & Immunity, Institute of Immunity & Transplantation, University College London, London, UK., Amin OE; Division of Infection & Immunity, Institute of Immunity & Transplantation, University College London, London, UK., Kucykowicz S; Division of Infection & Immunity, Institute of Immunity & Transplantation, University College London, London, UK., Heemskerk MH; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Davidson B; Division of Surgery, University College London, London, UK.; Royal Free London NHS Foundation Trust, London, UK., Meyer T; Royal Free London NHS Foundation Trust, London, UK.; Cancer Institute, University College London, London, UK., Grove J; Division of Infection & Immunity, Institute of Immunity & Transplantation, University College London, London, UK., Stauss HJ; Division of Infection & Immunity, Institute of Immunity & Transplantation, University College London, London, UK., Pineda-Torra I; Division of Medicine, University College London, London, UK., Jolly C; Division of Infection & Immunity, Institute of Immunity & Transplantation, University College London, London, UK., Jury EC; Division of Medicine, University College London, London, UK., McKeating JA; Nuffield Department of Medicine, Oxford University, Oxford, UK., Maini MK; Division of Infection & Immunity, Institute of Immunity & Transplantation, University College London, London, UK. m.maini@ucl.ac.uk.

المصدر: Nature communications [Nat Commun] 2021 May 14; Vol. 12 (1), pp. 2814. Date of Electronic Publication: 2021 May 14.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Enzyme Inhibitors/*pharmacology , Hepatitis B virus/*drug effects , Sterol O-Acyltransferase/*antagonists & inhibitors , T-Lymphocytes/*drug effects , T-Lymphocytes/*metabolism, CD8-Positive T-Lymphocytes/drug effects ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/metabolism ; Carcinoma, Hepatocellular/drug therapy ; Carcinoma, Hepatocellular/virology ; Drug Therapy, Combination ; Enzyme Inhibitors/administration & dosage ; Hepatitis B virus/immunology ; Hepatitis B virus/pathogenicity ; Hepatitis B, Chronic/drug therapy ; Humans ; Immune Checkpoint Inhibitors/administration & dosage ; Immune Checkpoint Inhibitors/pharmacology ; In Vitro Techniques ; Liver/drug effects ; Liver/immunology ; Liver/virology ; Liver Neoplasms/drug therapy ; Liver Neoplasms/virology ; T-Lymphocytes/immunology

المؤلفون: Lichtenegger FS; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany.; Present address: Roche Innovation Center Munich Penzberg Germany., Schnorfeil FM; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Heidelberg Germany.; Present address: Medigene AG Planegg Germany., Rothe M; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany., Deiser K; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany., Altmann T; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany., Bücklein VL; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany., Köhnke T; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany., Augsberger C; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany., Konstandin NP; Department of Medicine III University Hospital, LMU Munich Munich Germany., Spiekermann K; Department of Medicine III University Hospital, LMU Munich Munich Germany., Moosmann A; DZIF Research Group 'Host Control of Viral Latency and Reactivation' (HOCOVLAR) Helmholtz Zentrum München Munich Germany., Boehm S; Max von Pettenkofer Institute LMU Munich Munich Germany., Boxberg M; Institute of Pathology Technical University of Munich Munich Germany., Heemskerk MH; Department of Hematology Leiden University Medical Center Leiden The Netherlands., Goerlich D; Institute of Biostatistics and Clinical Research University of Muenster Muenster Germany., Wittmann G; Department of Transfusion Medicine, Cellular Therapeutics and Hemostaseology University Hospital LMU Munich Munich Germany., Wagner B; Department of Transfusion Medicine, Cellular Therapeutics and Hemostaseology University Hospital LMU Munich Munich Germany., Hiddemann W; Department of Medicine III University Hospital, LMU Munich Munich Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Heidelberg Germany., Schendel DJ; Medigene AG Planegg Germany., Kvalheim G; Department of Cellular Therapy The Norwegian Radium Hospital Oslo University Hospital Oslo Norway., Bigalke I; Department of Cellular Therapy The Norwegian Radium Hospital Oslo University Hospital Oslo Norway.; Present address: BioNTech IMFS Idar-Oberstein Germany., Subklewe M; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Heidelberg Germany.

المصدر: Clinical & translational immunology [Clin Transl Immunology] 2020 Mar 03; Vol. 9 (3), pp. e1117. Date of Electronic Publication: 2020 Mar 03 (Print Publication: 2020).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons Australia, Ltd. on behalf of Australasian Society for Immunology Inc Country of Publication: Australia NLM ID: 101638268 Publication Model: eCollection Cited Medium: Print ISSN: 2050-0068 (Print) Linking ISSN: 20500068 NLM ISO Abbreviation: Clin Transl Immunology Subsets: PubMed not MEDLINE

المؤلفون: van der Lee DI; Department of Hematology, and., Reijmers RM; Department of Hematology, and., Honders MW; Department of Hematology, and., Hagedoorn RS; Department of Hematology, and., de Jong RC; Department of Hematology, and., Kester MG; Department of Hematology, and., van der Steen DM; Department of Hematology, and., de Ru AH; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands., Kweekel C; Department of Hematology, and., Bijen HM; Department of Hematology, and., Jedema I; Department of Hematology, and., Veelken H; Department of Hematology, and., van Veelen PA; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, Netherlands., Heemskerk MH; Department of Hematology, and., Falkenburg JHF; Department of Hematology, and., Griffioen M; Department of Hematology, and.

المصدر: The Journal of clinical investigation [J Clin Invest] 2019 Feb 01; Vol. 129 (2), pp. 774-785. Date of Electronic Publication: 2019 Jan 14.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

مواضيع طبية MeSH: Adoptive Transfer* , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/immunology , Leukemia, Myeloid, Acute*/pathology , Leukemia, Myeloid, Acute*/therapy , Mutation* , Neoplasm Proteins*/genetics , Neoplasm Proteins*/immunology , Nuclear Proteins*/genetics , Nuclear Proteins*/immunology , Peptides*/genetics , Peptides*/immunology, Animals ; CD4-Positive T-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/pathology ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/pathology ; Female ; HLA-A2 Antigen/genetics ; HLA-A2 Antigen/immunology ; Humans ; Male ; Mice ; Mice, Inbred NOD ; Mice, SCID ; Nucleophosmin ; Transduction, Genetic ; Xenograft Model Antitumor Assays

المؤلفون: Luk SJ; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., van der Steen DM; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Hagedoorn RS; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Jordanova ES; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Center for Gynecological Oncology Amsterdam, Department of Obstetrics and Gynecology, VU University Medical Center, Amsterdam, The Netherlands., Schilham MW; Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands., Bovée JV; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Cleven AH; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Falkenburg JF; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Szuhai K; Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, The Netherlands., Heemskerk MH; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.

المصدر: Oncoimmunology [Oncoimmunology] 2018 Sep 11; Vol. 7 (12), pp. e1507600. Date of Electronic Publication: 2018 Sep 11 (Print Publication: 2018).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE

المؤلفون: Jahn L; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Hombrink P; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Hematopoiesis, Sanquin Research, Amsterdam, The Netherlands., Hagedoorn RS; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Kester MG; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., van der Steen DM; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Rodriguez T; Research and Development, Bellicum Pharmaceuticals, Inc., Houston, TX., Pentcheva-Hoang T; Research and Development, Bellicum Pharmaceuticals, Inc., Houston, TX., de Ru AH; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands., Schoonakker MP; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Meeuwsen MH; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Griffioen M; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., van Veelen PA; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands., Falkenburg JH; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Heemskerk MH; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.

المصدر: Blood [Blood] 2017 Mar 09; Vol. 129 (10), pp. 1284-1295. Date of Electronic Publication: 2017 Jan 04.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy, Adoptive/*methods , Lymphoma, Non-Hodgkin/*immunology , Multiple Myeloma/*immunology , Receptors, Antigen, T-Cell/*immunology , Trans-Activators/*antagonists & inhibitors, Animals ; Cell Line, Tumor ; Flow Cytometry ; Genetic Engineering/methods ; Humans ; Mice ; T-Lymphocytes/immunology ; Xenograft Model Antitumor Assays

المؤلفون: van Bergen CA, van Luxemburg-Heijs SA, de Wreede LC, Eefting M, von dem Borne PA, van Balen P, Heemskerk MH, Mulder A, Claas FH, Navarrete MA, Honders WM, Rutten CE, Veelken H, Jedema I, Halkes CJ, Griffioen M, Falkenburg JH

المصدر: The Journal of clinical investigation [J Clin Invest] 2017 Feb 01; Vol. 127 (2), pp. 517-529. Date of Electronic Publication: 2017 Jan 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, Neoplasm/*immunology , CD8-Positive T-Lymphocytes/*immunology , Graft vs Leukemia Effect/*immunology , Leukemia/*immunology , Minor Histocompatibility Antigens/*immunology, Antigens, Neoplasm/genetics ; Female ; Graft vs Host Disease/genetics ; Graft vs Host Disease/immunology ; Graft vs Leukemia Effect/genetics ; Humans ; Leukemia/genetics ; Leukemia/therapy ; Male ; Minor Histocompatibility Antigens/genetics

المؤلفون: Jolink H; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands; Department of Infectious Diseases, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands. Electronic address: h.jolink@lumc.nl., de Boer R; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Hombrink P; Sanquin Research and Landsteiner Laboratory, 1066 CX Amsterdam, The Netherlands., Jonkers RE; Department of Respiratory Medicine, Academic Medical Centre, 1105 AZ Amsterdam, The Netherlands., van Dissel JT; Department of Infectious Diseases, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Falkenburg JH; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Heemskerk MH; Department of Hematology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.

المصدر: The Journal of infection [J Infect] 2017 Jan; Vol. 74 (1), pp. 81-88. Date of Electronic Publication: 2016 Nov 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: W.B. Saunders Country of Publication: England NLM ID: 7908424 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2742 (Electronic) Linking ISSN: 01634453 NLM ISO Abbreviation: J Infect Subsets: MEDLINE

مواضيع طبية MeSH: Aspergillus fumigatus/*immunology , Cytokines/*immunology , Interleukin-17/*biosynthesis , Invasive Pulmonary Aspergillosis/*immunology , Lung/*immunology , Th17 Cells/*immunology, Aged ; CD4-Positive T-Lymphocytes/immunology ; Cytokines/biosynthesis ; Female ; Humans ; Interleukin-17/immunology ; Invasive Pulmonary Aspergillosis/microbiology ; Lung/microbiology ; Lymphocyte Activation ; Male ; Middle Aged ; Phenotype ; Th1 Cells/immunology

المؤلفون: Jahn L; Department of Hematology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands., van der Steen DM; Department of Hematology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands., Hagedoorn RS; Department of Hematology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands., Hombrink P; Department of Hematology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.; Department of Hematopoiesis, Sanquin Research, 1006 AD Amsterdam, The Netherlands., Kester MG; Department of Hematology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands., Schoonakker MP; Department of Hematology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands., de Ridder D; Department of Hematology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands., van Veelen PA; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.; Center for Proteomics and Metabolomics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands., Falkenburg JH; Department of Hematology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands., Heemskerk MH; Department of Hematology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.

المصدر: Oncotarget [Oncotarget] 2016 Nov 22; Vol. 7 (47), pp. 77021-77037.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

مواضيع طبية MeSH: Antigens, CD20/*genetics , Leukemia, B-Cell/*therapy , Lymphoma, B-Cell/*therapy , Receptors, Antigen, T-Cell/*genetics, Antigens, CD20/immunology ; Antigens, CD20/metabolism ; CD8-Positive T-Lymphocytes/immunology ; Genetic Therapy ; HLA-A2 Antigen/immunology ; Humans ; K562 Cells ; Leukemia, B-Cell/genetics ; Leukemia, B-Cell/immunology ; Lymphoma, B-Cell/genetics ; Lymphoma, B-Cell/immunology ; Receptors, Antigen, T-Cell/immunology